2022 American Transplant Congress
OPTN Required SARS-CoV-2 Lower Respiratory Testing for Lung Donors: Early Impact on Patient Safety and Organ Utilization
*Purpose: The OPTN implemented emergency policy on 5/27/21 requiring lower respiratory testing (LRT) by nucleic acid test (NAT) for SARS-CoV-2 (COVID-19) for all potential deceased…2022 American Transplant Congress
Effect of Prophylactic Treatment of Osteoporosis on the Progression of Bone Mineral Density and Fractures in Lung Transplant Recipients – A Five-Year, Single-Center Experience
*Purpose: The incidence of osteoporotic fractures in lung transplant recipients (LTxR) is 35-50%. Due to this high incidence, we perform regular DEXA scans [pre-Tx, every…2022 American Transplant Congress
Assessment of Letermovir as Universal Prophylaxis for Cytomegalovirus Infection in Lung Transplant Recipients
*Purpose: Cytomegalovirus (CMV) poses a significant concern in the post-operative management of lung transplant (LT) recipients. Current recommended prophylactic strategies with ganciclovir (GCV) or valganciclovir…2022 American Transplant Congress
Effects of Pre-Lung Transplantation Pulmonary Rehabilitation on Functional Capacity and Quality of Life
*Purpose: Pulmonary rehabilitation (PR) prior lung transplantation (LT) has been effective in reducing post transplantation complications. However, few studies have examined the effect of pre-lung…2022 American Transplant Congress
Data-Driven Clustering Distinguishes Infection from Rejection During Hospital Admissions Following Pediatric Lung Transplantation
*Purpose: When lung transplantation patients are admitted with respiratory symptoms, distinguishing between episodes of infection and rejection is central to determining immunosuppressive management.*Methods: Data comprising…2022 American Transplant Congress
Single Center Retrospective Study Examining the Incidence of Chronic Kidney Disease After Lung Transplantation and Its Associated Risk Factors
*Purpose: To examine the incidence of chronic kidney disease (CKD) after lung transplantation and to evaluate the recipient-related risk factors associated with the development of…2022 American Transplant Congress
Pooled Prevalence of Pulmonary Embolism in Lung Transplant Recipients – A Meta-Analysis
Department of Pulmonary and Critical Care, Cedars Sinai Medical Center, Los Angeles, CA
*Purpose: Similar to other operations, lung transplantation surgery has been associated with an increased risk of venous thromboembolism. While various studies have aimed to estimate…2021 American Transplant Congress
Impact Analysis of Virtual Transplant Ambulatory Pharmacist During Covid-19
Massachusetts General Hospital, Boston, MA
*Purpose: During the COVID-19 pandemic, transplant centers were challenged to meet the demand for new telemedicine strategies. High-risk immunocompromised patients, such as lung transplant recipients…2021 American Transplant Congress
Elexacaftor/ivacaftor/tezacaftor in Lung Transplant Recipients: A Case Series
1University of Chicago Medicine, Chicago, IL, 2Roosevelt University, Chicago, IL
*Purpose: Little data is published describing the safety or efficacy of elexacaftor/ivacaftor/tezacaftor in lung transplant recipients. Even though it is not expected to offer pulmonary…2021 American Transplant Congress
Renal Preservation with Belatacept-Based versus Everolimus-Based Immunosuppression in Lung Transplant Recipients
*Purpose: Renal dysfunction is one of the most common long-term complications among lung transplant recipients (LTRs). Calcineurin-inhibitor (CNI) nephrotoxicity is a recognized contributor to renal…
- « Previous Page
- 1
- 2
- 3
- 4
- …
- 10
- Next Page »